The FDA issued approvals for Pfizer and Moderna's 2026 COVID-19 vaccines on Thursday, but is recommending them for the same ...

Sword Health, a digital therapeutics company that started in the physical therapy space, has acquired digital mental health ...

The US FDA has green lit ViiV Healthcare’s Tivicay PD (dolutegravir) for the treatment of HIV-1 in children weighing at least ...

The ambition to build a Phase I oncology clinical development centre can be deceptively simple. The temptation is to ...

The Marcus Evans AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma conference will explore how pharma ...

Medical technology company Boston Scientific became the target of a cyberattack this week, which disrupted some of its IT ...

Pharmaceutical portfolio decision-making is facing structural pressure. Patent expirations, rising development costs, ...

AstraZeneca and Amgen have announced the first Phase III results for Tezspire (tezepelumab) in eosinophilic oesophagitis (EoE ...

Pharma R&D leaders in Europe are facing a rare convergence of pressures: a historic patent cliff, tightening EU/UK pricing ...

Jazz Pharmaceuticals has been granted US approval for two combinations of its cancer drug Ziihera for people with advanced ...

While obesity may be a fast-growing cost area, it's far from the largest -- only 10% of employers surveyed put it in their ...

Europe. Whilst long recognised as Europe's largest partnering conference, it's now expanding to become the continent's most ...